EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sp1 mediated the inhibitory effect of glutamate on pulmonary surfactant synthesis

Xiao-Hong Li, Jie-Jun Fu, Xiao-Juan Shi, Yun-Na Zhang, Min Shao, Shao-Jie Yue, Chen Li iD, Zi-Qiang Luo iD

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0289530 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Xiao-Hong Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Lung Injury, Pulmonary Surfactants, Sp1 Transcription Factor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovative Research Group Project of the National Natural Science Foundation of China, the National Natural Science Foundations of China, the Natural Science Foundation of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Studies have shown that the release of endogenous glutamate (Glu) participates in lung injury by activating N-methyl-D-aspartate receptor (NMDAR), but the mechanism is still unclear. This study was to investigate the effects and related mechanisms of Glu on the lipid synthesis of pulmonary surfactant (PS) in isolated rat lung tissues.

Methods

The cultured lung tissues of adult SD rats were treated with Glu. The amount of [ 3 H]-choline incorporation into phosphatidylcholine (PC) was detected. RT-PCR and Western blot were used to detect the changes of mRNA and protein expression of cytidine triphosphate: phosphocholine cytidylyltransferase alpha (CCTα), a key regulatory enzyme in PC biosynthesis. Western blot was used to detect the expression of NMDAR1, which is a functional subunit of NMDAR. Specific protein 1 (Sp1) expression plasmids were used. After transfected with Sp1 expression plasmids, the mRNA and protein levels of CCTα were detected by RT-PCR and Western blot in A549 cells. After treated with NMDA and MK-801, the mRNA and protein levels of Sp1 were detected by RT-PCR and Western blot in A549 cells.

Results

Glu decreased the incorporation of [ 3 H]-choline into PC in a concentration- and time- dependent manner. Glu treatment significantly reduced the mRNA and protein levels of CCTα in lungs. Glu treatment up-regulated NMDAR1 protein expression, and the NMDAR blocker MK-801 could partially reverse the reduction of [ 3 H]-choline incorporation induced by Glu (10 −4 mol/L) in lungs. After transfected with Sp1 plasmid for 30 h, the mRNA and protein expression levels of CCTα were increased and the protein expression of Sp1 was also up-regulated. After A549 cells were treated with NMDA, the level of Sp1 mRNA did not change significantly, but the expression of nucleus protein in Sp1 was significantly decreased, while the expression of cytoplasmic protein was significantly increased. However, MK-801could reverse these changes.

Conclusions

Glu reduced the biosynthesis of the main lipid PC in PS and inhibited CCTα expression by activating NMDAR, which were mediated by the inhibition of the nuclear translocation of Sp1 and the promoter activity of CCTα. In conclusion, NMDAR-mediated Glu toxicity leading to impaired PS synthesis may be a potential pathogenesis of lung injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung InjuryPulmonary SurfactantsSp1 Transcription FactorAnimalsRatsCholineCholine-Phosphate CytidylyltransferaseDizocilpine MaleateGlutamic AcidN-MethylaspartatePhosphatidylcholinesRats, Sprague-DawleyRNA, Messenger

Substanzen

CholineCholine-Phosphate CytidylyltransferaseDizocilpine MaleateGlutamic AcidN-MethylaspartatePhosphatidylcholinesPulmonary SurfactantsRNA, MessengerSp1 Transcription Factor

Autor:innen und Institutionen

  • Department of Pathology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Department of Physiology, Xiangya School of Medicine, Central South University, Changsha, Hunan, China.
  • Department of Pediatrics, Xiangya Hospital, Central South University, Changsha, China.
  • Department of Physiology, Changzhi Medical College, Changzhi, Shanxi, China.
  • Hunan Key Laboratory of Organ Fibrosis, Central South University, Changsha, Hunan, China.

ORCID-Profile: Chen Li, Zi-Qiang Luo

Förderung

  • Innovative Research Group Project of the National Natural Science Foundation of China
  • the National Natural Science Foundations of China
  • the Natural Science Foundation of Hunan Province

Zitieren

APA

Li, X. H., Fu, J. J., Shi, X. J., Zhang, Y. N., Shao, M., Yue, S. J., Li, C., & Luo, Z. Q. (2023). Sp1 mediated the inhibitory effect of glutamate on pulmonary surfactant synthesis. PLOS ONE. https://doi.org/10.1371/journal.pone.0289530

Vancouver

Li XH, Fu JJ, Shi XJ, Zhang YN, Shao M, Yue SJ, et al. Sp1 mediated the inhibitory effect of glutamate on pulmonary surfactant synthesis. PLOS ONE. 2023. doi:10.1371/journal.pone.0289530

BibTeX
@article{Li2023,
  author = {Li, Xiao-Hong and Fu, Jie-Jun and Shi, Xiao-Juan and Zhang, Yun-Na and Shao, Min and Yue, Shao-Jie and Li, Chen and Luo, Zi-Qiang},
  title = {Sp1 mediated the inhibitory effect of glutamate on pulmonary surfactant synthesis},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0289530}
}
Kostenlos starten →